Zyla Life Sciences Revenue
Zyla Life Sciences reported Revenue of $19.07 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-05-14
- Zyla Life Sciences revenues for the quarter ending 2020-03-31 was $19.07M.
- Zyla Life Sciences revenues for the quarter ending 2019-09-30 was $22.39M, a 174.57% increase year-over-year.
- Zyla Life Sciences revenues for the quarter ending 2019-06-30 was $22.03M, a 196.04% increase year-over-year.
- Zyla Life Sciences revenues for the quarter ending 2018-12-31 was $8.50M, a 8.88% increase year-over-year.
- Zyla Life Sciences revenues for fiscal 2018 was $30.35M, a 16.13% increase from fiscal 2017.
- Zyla Life Sciences revenues for fiscal 2017 was $26.14M, a 54.07% increase from fiscal 2016.
- Zyla Life Sciences revenues for fiscal 2016 was $16.96M, a 25.69% decline from fiscal 2015.
- Zyla Life Sciences revenues for fiscal 2015 was $22.83M, a 1089.06% increase from fiscal 2014.
| Period end | Revenues 1 month | Revenues 2 month | Revenues 3 month | Revenues 5 month | Revenues 6 month | Revenues 8 month | Revenues 9 month | Revenues 11 month | Revenues 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $19.07M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | $79.53M 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | $22.39M 10-Q · filed 2019-11-14 | $44.42M derived: sum of 2 quarters · filed 2019-11-14 | $60.23M 10-Q · filed 2019-11-14 | ||||||
| 2019-06-30 | $22.03M 10-Q · filed 2019-08-13 | $37.84M 10-Q · filed 2019-08-13 | |||||||
| 2019-03-31 | $15.81M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | $1.77M 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $16.65M derived: sum of 2 quarters · filed 2020-03-26 | $24.09M derived: sum of 3 quarters · filed 2020-03-26 | $30.35M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | $8.15M 10-Q · filed 2019-11-14 | $15.60M derived: sum of 2 quarters · filed 2019-11-14 | $21.86M 10-Q · filed 2019-11-14 | $29.66M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $7.44M 10-Q · filed 2018-08-09 | $13.70M 10-Q · filed 2018-08-09 | $21.51M derived: sum of 3 quarters · filed 2018-08-09 | $28.16M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2018-03-31 | $6.26M 10-Q · filed 2018-05-10 | $14.06M derived: sum of 2 quarters · filed 2018-05-10 | $20.71M derived: sum of 3 quarters · filed 2018-11-19 | $26.97M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-12-31 | $7.80M 10-K · filed 2018-03-16 | $14.45M derived: sum of 2 quarters · filed 2018-11-19 | $20.71M derived: sum of 3 quarters · filed 2018-11-19 | $26.14M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $6.65M 10-Q · filed 2018-11-19 | $12.91M derived: sum of 2 quarters · filed 2018-11-19 | $18.33M 10-Q · filed 2018-11-19 | $24.47M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-06-30 | $6.25M 10-Q · filed 2018-08-09 | $11.68M 10-Q · filed 2018-08-09 | $17.82M derived: sum of 3 quarters · filed 2018-08-09 | $22.53M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $5.43M 10-Q · filed 2018-05-10 | $11.57M derived: sum of 2 quarters · filed 2018-05-10 | $16.28M derived: sum of 3 quarters · filed 2018-05-10 | $19.73M derived: sum of 4 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | $6.14M 10-K · filed 2018-03-16 | $10.85M derived: sum of 2 quarters · filed 2018-03-16 | $14.30M derived: sum of 3 quarters · filed 2018-03-16 | $16.96M 10-K · filed 2018-03-16 | |||||
| 2016-09-30 | $4.71M 10-K · filed 2018-03-16 | $8.16M derived: sum of 2 quarters · filed 2018-03-16 | $10.82M 10-Q · filed 2017-11-08 | $30.20M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-06-30 | $3.45M 10-K · filed 2018-03-16 | $6.11M 10-Q · filed 2017-08-09 | $25.49M derived: sum of 3 quarters · filed 2018-03-16 | $27.18M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-03-31 | $2.66M 10-K · filed 2018-03-16 | $22.04M derived: sum of 2 quarters · filed 2018-03-16 | $23.73M derived: sum of 3 quarters · filed 2018-03-16 | $24.69M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $19.38M 10-K · filed 2017-03-13 | $21.07M derived: sum of 2 quarters · filed 2017-03-13 | $22.02M derived: sum of 3 quarters · filed 2017-03-13 | $22.83M 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | $1.69M 10-K · filed 2017-03-13 | $2.65M derived: sum of 2 quarters · filed 2017-03-13 | $3.43M 10-Q · filed 2016-11-08 | $4.28M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-06-30 | $959.00K 10-K · filed 2017-03-13 | $1.74M 10-Q · filed 2016-08-05 | $2.59M derived: sum of 3 quarters · filed 2017-03-13 | $2.94M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-03-31 | $805.00K 10-K · filed 2017-03-13 | $1.63M derived: sum of 2 quarters · filed 2017-03-13 | $1.98M derived: sum of 3 quarters · filed 2017-03-13 | $2.47M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2014-12-31 | $826.00K 10-K · filed 2016-03-11 | $1.17M derived: sum of 2 quarters · filed 2016-03-11 | $1.66M derived: sum of 3 quarters · filed 2016-03-11 | $1.92M 10-K · filed 2017-03-13 | |||||
| 2014-09-30 | $346.00K 10-K · filed 2016-03-11 | $836.00K derived: sum of 2 quarters · filed 2016-03-11 | $1.09M 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | $490.00K 10-K · filed 2016-03-11 | $746.00K 10-Q · filed 2015-08-07 | |||||||
| 2014-03-31 | $256.00K 10-K · filed 2016-03-11 | ||||||||
| 2012-12-31 | $1.20M 10-K · filed 2015-03-16 |